Personalized cancer vaccines

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

217 papers

Showing 25-36 of total 217 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedDirectly related

AI-driven genotype-phenotype modeling: a framework integrating multi-modal single-cell genomics and reverse vaccinology for de novo design of multi-epitope cancer vaccines.

Mallik M; Mollick SA

Jan 1, 2026Frontiers in genetics

2026PubMedDirectly related

Clinical landscape of therapeutic vaccines for ovarian cancer: current status, challenges, and future directions.

Shan Y; Wang Q; Wan W; Zhang Y; Chu Y

Jan 1, 2026Journal of ovarian research

2026PubMedDirectly related

Microbiota-derived self-adjuvanting exopolysaccharide-based codelivery system for potent cancer immunotherapy.

Bao X; Shi J; Zhang H; Li C; Liang Y; Pan N; Fu Y; Su X; Wang W; Wang T; Zhang L; Wang X

Jan 1, 2026Materials today. Bio

2026PubMedDirectly related

Predicting Neoantigen Immunogenicity from In Vivo Immune Editing.

Sears TJ; Lee KH; Munoz Perez M; Rasmussen R; Pagadala MS; Tanaka K; Subramanian A; Moding EJ; Zanetti M; Carter H

Jan 1, 2026

2026PubMedDirectly related

Vaccines for Cancer: A Translational Science Review.

Disis ML; Chun BMN; Dhillon KK; Liao JB; Hunter N; Cecil DL

Jan 1, 2026JAMA

2026PubMedDirectly related

mRNA Therapeutics Beyond Infectious Diseases: Expanding Therapeutic Applications and Future Perspectives.

Dejen GM

Jan 1, 2026Immunity, inflammation and disease

2026PubMedDirectly related

Personalized neoantigen mRNA vaccines for pancreatic cancer: the role of lipid nanoparticle delivery systems.

Debnath D

Jan 1, 2026Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences

2026PubMedSupporting evidence

Ferroptosis in the Tumor Immune Microenvironment: Mechanisms, Nanomedicine, and Immunotherapy.

Sayed U; Rizaev J; Turaev R; Mamedova G; Badraldin SQ; Hassan YM; Tailor NK; Singh R

Jan 1, 2026Journal of cellular biochemistry

2026PubMedDirectly related

Synthetic consensus DNA vaccines against Merkel cell polyomavirus large and small T antigens induce robust polyfunctional T cell responses.

Bhojnagarwala PS; Duperret EK; Trautz A; Weiner DB

Jan 1, 2026

2026PubMedSupporting evidence

Biomaterial-based mitochondria-targeted nanomedicine for remodeling the breast cancer tumor microenvironment and overcoming therapy resistance.

Gu Y; Qu P; Li X; Shi J; Zhou M; Bai Z; Li G; Cheng P; Li X; Chen F; Liang Q

Jan 1, 2026

2026PubMedDirectly related

Beyond the Generic Tumor: Engineering Patient-Specific Immune Ecosystems for Cancer.

Anvari S; Naghinezhad J; Farokhi R; Rahnama MA; Hoseinzadeh S; Nikbakht M; Ahmadvand M

Jan 1, 2026Critical reviews in oncology/hematology

2026PubMedDirectly related

Target, silence, replace: a review on RNA-based drugs in modern medicine.

Mundlia P; Singh SP; Pothal P; Thakur T; Kathuria R; Maurya S; Sharma A; Goel H; Pandey A; Ranawat P; Singh G; Barnwal RP

Jan 1, 2026Frontiers in cell and developmental biology